Pharma Mar SA
Isabel Pardos has over 25 years of experience in the pharmaceutical industry, currently serving as a Clinical Operations Senior Manager at PharmaMar since September 2004. In this role, Isabel has demonstrated expertise in overseeing clinical operations and project management. Prior to joining PharmaMar, Isabel worked at PAREXEL from June 1998 to September 2004, where responsibilities included Project Manager/Clinical Lead and Clinical Research Associate (CRA), further showcasing a strong background in managing clinical trials and leading projects.
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.